Clinical Trials List
Protocol NumberTAK-079-1006
Completed
2022-08-01 - 2023-08-14
Phase I
Recruiting2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- CHUN-FU LAI 無
- 陳怡婷 無
- 楊紹佑 無
- SHUEI-LIONG LIN 無
- VIN-CENT Wu 無
- YU-HSIANG CHOU 無
- - - 無
- 潘思宇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mei-Yi Wu 無
- Chia-Te Liao 無
- Cai-Mei Zheng 無
- Li-Yee Hong 無
- YUNG-HO HSU 無
- Yu-Wei Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
16 participants
